Interstitial high-dose-rate-brachytherapy in advanced esthesioneuroblastoma.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 18641524.
- Also identified by DOI 10.1097/MLG.0b013e3181801d05.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Esthesioneuroblastoma is a rare neuroectodermal tumor of the nasal vault with an aggressive biological behavior that is characterized by local recurrence, atypical distant metastasis, and poor long-term prognosis. The treatment regimen consists of surgical resection, radiation therapy, and chemotherapy in various, mainly stage-dependent, combinations. We report two cases of primary metastatic and locally recurrent disease, which were treated with computed tomography-guided interstitial high-dose-rate brachytherapy in palliative and curative intent, respectively. Computed tomography-guided interstitial high-dose-rate brachytherapy should be considered as a feasible treatment option for advanced esthesioneuroblastoma.
Medical subject headings
- Brachytherapy
- Esthesioneuroblastoma, Olfactory
- Nasal Cavity
- Nose Neoplasms